NephRx Corp.
This article was originally published in Start Up
Executive Summary
Although no one has yet developed a drug for kidney failure, researchers have long maintained the hope that reversing kidney failure is an attainable goal, because the kidney is one of the few organs in the body capable of regenerating. NephRx Corp. is one of this number of hopefuls; it believes its family of growth factors will repair damaged renal cells, and potentially also serve in degenerative gastrointestinal disorders.